Literature DB >> 18819921

Regulation of the Met receptor-tyrosine kinase by the protein-tyrosine phosphatase 1B and T-cell phosphatase.

Veena Sangwan1, Grigorios N Paliouras, Jasmine V Abella, Nadia Dubé, Anie Monast, Michel L Tremblay, Morag Park.   

Abstract

The non-receptor protein-tyrosine phosphatases (PTPs) 1B and T-cell phosphatase (TCPTP) have been implicated as negative regulators of multiple signaling pathways including receptor-tyrosine kinases. We have identified PTP1B and TCPTP as negative regulators of the hepatocyte growth factor receptor, the Met receptor-tyrosine kinase. In vivo, loss of PTP1B or TCPTP enhances hepatocyte growth factor-mediated phosphorylation of Met. Using substrate trapping mutants of PTP1B or TCPTP, we have demonstrated that both phosphatases interact with Met and that these interactions require phosphorylation of twin tyrosines (Tyr-1234/1235) in the activation loop of the Met kinase domain. Using confocal microscopy, we show that trapping mutants of both PTP1B and the endoplasmic reticulum-targeted TCPTP isoform, TC48, colocalize with Met and that activation of Met enables the nuclear-localized isoform of TCPTP, TC45, to exit the nucleus. Using small interfering RNA against PTP1B and TCPTP, we demonstrate that phosphorylation of Tyr-1234/1235 in the activation loop of the Met receptor is elevated in the absence of either PTP1B or TCPTP and further elevated upon loss of both phosphatases. This enhanced phosphorylation of Met corresponds to enhanced biological activity and cellular invasion. Our data demonstrate that PTP1B and TCPTP play distinct and non-redundant roles in the regulation of the Met receptor-tyrosine kinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819921      PMCID: PMC2662243          DOI: 10.1074/jbc.M805916200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  The protein-tyrosine phosphatase TCPTP regulates epidermal growth factor receptor-mediated and phosphatidylinositol 3-kinase-dependent signaling.

Authors:  T Tiganis; B E Kemp; N K Tonks
Journal:  J Biol Chem       Date:  1999-09-24       Impact factor: 5.157

Review 2.  PTP1B and TC-PTP: regulators of transformation and tumorigenesis.

Authors:  Matthew Stuible; Karen M Doody; Michel L Tremblay
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

3.  Mechanism of met oncogene activation.

Authors:  M Park; M Dean; C S Cooper; M Schmidt; S J O'Brien; D G Blair; G F Vande Woude
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

4.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

5.  The transmembrane protein tyrosine phosphatase RPTPsigma modulates signaling of the epidermal growth factor receptor in A431 cells.

Authors:  E Suárez Pestana; T Tenev; S Gross; B Stoyanov; M Ogata; F D Böhmer
Journal:  Oncogene       Date:  1999-07-15       Impact factor: 9.867

Review 6.  From Tpr-Met to Met, tumorigenesis and tubes.

Authors:  P Peschard; M Park
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

7.  Effects of small interference RNA against PTP1B and TCPTP on insulin signaling pathway in mouse liver: evidence for non-synergetic cooperation.

Authors:  Jianfeng Xu; Lin Li; Jie Hong; Weida Huang
Journal:  Cell Biol Int       Date:  2006-09-23       Impact factor: 3.612

8.  Met provides essential signals for liver regeneration.

Authors:  Malgorzata Borowiak; Alistair N Garratt; Torsten Wüstefeld; Michael Strehle; Christian Trautwein; Carmen Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

9.  Regulation of insulin signaling through reversible oxidation of the protein-tyrosine phosphatases TC45 and PTP1B.

Authors:  Tzu-Ching Meng; Deirdre A Buckley; Sandra Galic; Tony Tiganis; Nicholas K Tonks
Journal:  J Biol Chem       Date:  2004-06-10       Impact factor: 5.157

10.  Association of protein tyrosine phosphatases (PTPs)-1B with c-Met receptor and modulation of corneal epithelial wound healing.

Authors:  Azucena Kakazu; Guru Sharma; Haydee E P Bazan
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-07       Impact factor: 4.799

View more
  47 in total

1.  T cell protein tyrosine phosphatase (TCPTP) deficiency in muscle does not alter insulin signalling and glucose homeostasis in mice.

Authors:  K Loh; T L Merry; S Galic; B J Wu; M J Watt; S Zhang; Z-Y Zhang; B G Neel; T Tiganis
Journal:  Diabetologia       Date:  2011-11-29       Impact factor: 10.122

2.  An overview of the c-MET signaling pathway.

Authors:  Shawna Leslie Organ; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

3.  The zinc transporter Zip14 influences c-Met phosphorylation and hepatocyte proliferation during liver regeneration in mice.

Authors:  Tolunay Beker Aydemir; Harry S Sitren; Robert J Cousins
Journal:  Gastroenterology       Date:  2012-02-25       Impact factor: 22.682

4.  PTP1B targets the endosomal sorting machinery: dephosphorylation of regulatory sites on the endosomal sorting complex required for transport component STAM2.

Authors:  Matthew Stuible; Jasmine V Abella; Matthew Feldhammer; Misha Nossov; Veena Sangwan; Blagoy Blagoev; Morag Park; Michel L Tremblay
Journal:  J Biol Chem       Date:  2010-05-26       Impact factor: 5.157

5.  Thyroid Hormone Receptor-β Agonist GC-1 Inhibits Met-β-Catenin-Driven Hepatocellular Cancer.

Authors:  Elisabetta Puliga; Qian Min; Junyan Tao; Rong Zhang; Tirthadipa Pradhan-Sundd; Minakshi Poddar; Sucha Singh; Amedeo Columbano; Jinming Yu; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2017-08-12       Impact factor: 4.307

6.  Differential regulation of FGFR3 by PTPN1 and PTPN2.

Authors:  Jonathan R St-Germain; Paul Taylor; Wen Zhang; Zhihua Li; Troy Ketela; Jason Moffat; Benjamin G Neel; Suzanne Trudel; Michael F Moran
Journal:  Proteomics       Date:  2014-12-17       Impact factor: 3.984

7.  Advances in malignant pleural mesothelioma therapy: targeting EphA2 a novel approach.

Authors:  Najmunnisa Nasreen; Nazli Khodayari; Kamal A Mohammed
Journal:  Am J Cancer Res       Date:  2012-02-15       Impact factor: 6.166

8.  Combined Systemic Disruption of MET and Epidermal Growth Factor Receptor Signaling Causes Liver Failure in Normal Mice.

Authors:  Anastasia Tsagianni; Wendy M Mars; Bharat Bhushan; William C Bowen; Anne Orr; John Stoops; Shirish Paranjpe; George C Tseng; Silvia Liu; George K Michalopoulos
Journal:  Am J Pathol       Date:  2018-07-20       Impact factor: 4.307

9.  Phosphatome profiling reveals PTPN2, PTPRJ and PTEN as potent negative regulators of PKB/Akt activation in Ras-mutated cancer cells.

Authors:  Jasminka Omerovic; Michael J Clague; Ian A Prior
Journal:  Biochem J       Date:  2010-01-27       Impact factor: 3.857

10.  Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase.

Authors:  Elina Mattila; Heidi Marttila; Niko Sahlberg; Pekka Kohonen; Siri Tähtinen; Pasi Halonen; Merja Perälä; Johanna Ivaska
Journal:  BMC Cancer       Date:  2010-01-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.